|4Jan 31, 6:08 AM ET

Hornung William Karl 4

4 · Diffusion Pharmaceuticals Inc. · Filed Jan 31, 2022

Insider Transaction Report

Form 4
Period: 2022-01-27
Hornung William Karl
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-27+305,743305,743 total
    Exercise: $0.24Exp: 2032-01-27Common Stock (305,743 underlying)
Footnotes (1)
  • [F1]The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2022.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4